Enhancing research impact for food security - Strengthening ...
Research for Impact
3
Research for Impact To: The Australian Government Department of Health The Honourable Greg Hunt MP Federal Minister for Health and Ageing PO Box 647 Somerville, Vic 3912 Email: [email protected] August 31, 2021 Dear Mr Hunt, The Evidence-Based Medicine Consultancy Ltd (E-BMC Ltd) is a UK-based independent medical research company that contributes to the quality of healthcare globally through the rigorous evaluaXon of medical evidence to support clinical pracXce guidelines. The Frontline Covid CriXcal Care Alliance (FLCCC) Alliance is a U.S based non-profit humanitarian organizaXon made up of renowned, world-expert clinician-researchers whose sole mission over the past year has been to develop and disseminate the most effecXve treatment protocols for covid-19. We understand that the Australian government is anxious to keep cases at a minimum. Wide- spread availability of safe and effecXve vaccines for those who choose to get vaccinated has been challenging for most countries. In addiXon, covid vaccines may not be as effecXve against certain variants. It is our view that conXnuing success in controlling the pandemic must involve treaXng at the earliest signs of symptoms and/or a posiXve test result, which will help prevent deteriora- Xon and need for hospitalisaXon. Over the past four months, E-BMC Ltd has been working together with the FLCCC to encourage governments around the world to adopt re-purposed exisXng drugs for the early treatment of covid-19. One such drug is ivermecXn, a safe medicine which has been used for nearly 40 years to treat parasiXc infecXons. New evidence show that it has potent anXviral and anX-inflammatory properXes as well. E-BMC Ltd presented the evidence on ivermecXn to prevent and treat covid-19 to the BriXsh IvermecXn RecommendaXon Development (BiRD) panel in February 2021. The BiRD group in- cludes researchers and doctors from around the world who have been seeking effecXve treat- ments to combat the pandemic. The BiRD panel deliberated on the evidence for the use of iver- mecXn against covid-19, including evidence and consideraXons on cost, safety, acceptability, fea- sibility, equity and people’s values and preferences. The meeXng resulted in a recommendaXon in favour of ivermecXn as a covid-19 frontline therapy. 305 Northgate House, Upper Borough Walls, Bath BA1 1RG, United Kingdom. +44 7826 939 464 – [email protected] – www.e-bmc.co.uk Registered in England and Wales no. 08690151
Transcript of Research for Impact
Research for Impact
To:
The Australian Government Department of Health The Honourable Greg Hunt MP Federal Minister for Health and Ageing PO Box 647 Somerville, Vic 3912
Email: [email protected]
August 31, 2021
Dear Mr Hunt,
The Evidence-Based Medicine Consultancy Ltd (E-BMC Ltd) is a UK-based independent medical research company that contributes to the quality of healthcare globally through the rigorous evaluaXon of medical evidence to support clinical pracXce guidelines. The Frontline Covid CriXcal Care Alliance (FLCCC) Alliance is a U.S based non-profit humanitarian organizaXon made up of renowned, world-expert clinician-researchers whose sole mission over the past year has been to develop and disseminate the most effecXve treatment protocols for covid-19.
We understand that the Australian government is anxious to keep cases at a minimum. Wide-spread availability of safe and effecXve vaccines for those who choose to get vaccinated has been challenging for most countries. In addiXon, covid vaccines may not be as effecXve against certain variants. It is our view that conXnuing success in controlling the pandemic must involve treaXng at the earliest signs of symptoms and/or a posiXve test result, which will help prevent deteriora-Xon and need for hospitalisaXon.
Over the past four months, E-BMC Ltd has been working together with the FLCCC to encourage governments around the world to adopt re-purposed exisXng drugs for the early treatment of covid-19. One such drug is ivermecXn, a safe medicine which has been used for nearly 40 years to treat parasiXc infecXons. New evidence show that it has potent anXviral and anX-inflammatory properXes as well. E-BMC Ltd presented the evidence on ivermecXn to prevent and treat covid-19 to the BriXsh IvermecXn RecommendaXon Development (BiRD) panel in February 2021. The BiRD group in-cludes researchers and doctors from around the world who have been seeking effecXve treat-ments to combat the pandemic. The BiRD panel deliberated on the evidence for the use of iver-mecXn against covid-19, including evidence and consideraXons on cost, safety, acceptability, fea-sibility, equity and people’s values and preferences. The meeXng resulted in a recommendaXon in favour of ivermecXn as a covid-19 frontline therapy.
305 Northgate House, Upper Borough Walls, Bath BA1 1RG, United Kingdom. +44 7826 939 464 – [email protected] – www.e-bmc.co.uk
Registered in England and Wales no. 08690151
Both BiRD and FLCCC recommend ivermecXn be used for treatment of covid-19 in early out-pa-Xent disease. We recommend that ivermecXn be used at a dose of 0.4 mg/kg – 0.6 mg/kg, along with a number of adjunct therapeuXcs, which are detailed in the regularly updated I-MASK+ PrevenXon & Early Treatment Protocol . We strongly recommend that ivermecXn be 1
conXnued for 5 days or unXl recovered. For hospitalized covid paXents, please refer to the MATH+ Protocol . 2
We also recommend that ivermecXn be used as covid-19 prophylaxis on a large scale through mass distribuXon of ivermecXn in the dose of 0.2mg/kg (12mg for a 60 kg person) twice-weekly to adults to decrease transmission amongst the general populaXon in the current crisis. We be-lieve this will save thousands of lives and reduce the suffering of millions.
IvermecXn’s ability to beat covid-19 can be evidenced in many parts of the world, including the Dominican Republic, India, Zimbabwe and South Africa, as well as in other African countries where mass administraXon of ivermecXn against parasiXc infecXons is pracXced. More than 3.7 billion people have been treated with IvermecXn for parasiXc infecXons and it has been found to be extremely safe.
On behalf of our our members and our numerous affiliated organisaXons who have been provid-ing ethical medical guidance during this health emergency, we hope our message will be given the necessary alenXon for the beler health of Australians and the Australian economy.
Should you need any further informaXon, please do not hesitate to contact us via: [email protected].
Yours Sincerely,
Dr. Tess Lawrie on behalf of the BiRD Group, and Dr Pierre Kory on behalf of the FLCCC, and affili-ated organisaXons:
hlps://covid19criXcalcare.com/covid-19-protocols/i-mask-plus-protocol/ 1
hlps://covid19criXcalcare.com/wp-content/uploads/2021/01/FLCCC-Alliance-MATHplus-Protocol-ENGLISH.pdf2
305 Northgate House, Upper Borough Walls, Bath BA1 1RG, United Kingdom. +44 7826 939 464 – [email protected] – www.e-bmc.co.uk
Registered in England and Wales no. 08690151
ç
305 Northgate House, Upper Borough Walls, Bath BA1 1RG, United Kingdom. +44 7826 939 464 – [email protected] – www.e-bmc.co.uk
Registered in England and Wales no. 08690151
